Rochester, NY 6/9/2009 12:26:58 AM
AMEX - Afternoon GAINERS - Sinovac Biotech Ltd,SVA - Caraco Pharmaceutical Laboratories Ltd.,CPD - Tianyin Pharmaceutical Co., Inc,TPI - SOURCED WhisperFromWallStreet.com
Sinovac Biotech Ltd - Caraco Pharmaceutical Laboratories - Tianyin Pharmaceutical Co.
AMEX - Afternoon GAINERS - Sinovac Biotech Ltd,SVA - Caraco Pharmaceutical Laboratories Ltd.,CPD - Tianyin Pharmaceutical Co., Inc,TPI - SOURCED WhisperFromWallStreet.com
Sinovac Biotech Ltd,SVA
Chinese vaccine maker Sinovac Biotech Ltd. said it has begun production of a vaccine to prevent the H1N1 virus, also known as the swine flu. The company said it is currently able to produce up to 30 million doses of pandemic vaccine per year, and hopes to combine the H1N1 virus into a broader pandemic vaccine known as Panflu. Sinovac added that the number of doses it is able to manufacture will depend on how the H1N1 virus batches perform
ABOUT
Sinovac Biotech Ltd., a biopharmaceutical company, focuses on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases in China. Its portfolio of regulatory-approved products consists of vaccines against the hepatitis A, hepatitis B and influenza viruses. The company offers Healive, an inactivated hepatitis A vaccine; Bilive, a combination hepatitis A and B vaccine; Anflu, a split virus influenza vaccine; and Panflu, a vaccine against the H5N1 influenza virus. The company's pipeline vaccine candidates in the pre-clinical and clinical development phases include human vaccines for Enterovirus 71, Japanese encephalitis virus, and rabies; a vaccine for the SARS virus, which completed Phase I clinical trial; animal rabies vaccine; and a split viron vaccine for the H5N1 influenza virus, which completed Phase II clinical trial.
Last Trade: 3.14
Day's Range: 3.13 - 3.50
52wk Range: 0.75 - 4.08
Volume: 456,497
Change: Up 0.02 (0.64%)
---
If you are viewing this press release you are obviously interested in making money in the stock market. In today’s market investors need every tool available. WhisperfromWallStreet.com sends FREE alerts to our subscribers on stocks that we feel are ready to move within hours or days. So far in 2009 we have sent 36 stock alerts to our clients and the average price gain has been 88%. To add additional profits to your portfolio please take a minute and sign up for our free alerts. There is no risk to you and you will see just how accurate we are in our alerts.
Investors sign up for our FREE alerts at www.WhisperfromWallStreet.com
---
Caraco Pharmaceutical Laboratories Ltd.,CPD
Caraco Pharmaceutical Laboratories, Ltd. engages in the development, manufacture, and marketing of generic, prescription, and over-the-counter pharmaceuticals. The company offers Allopurinol, an anti-gout; Amifostine for injection used as oncology adjunct; Amlodipine Besylate tablets, Atenolol, Carvedilol, and Metoprolol Tartrate, which are antihypertensive drug/beta blockers; Baclofen and Tizanidine, which are skeletal muscle relaxants; Carbamazepine, Gabapentin, Phenytoin Sodium extended release capsules, Zonisamide, and Oxcarbazepine, which are anticonvulsants; Carbidopa and Levodopa ER for the treatment of Parkinson disease; and Carisoprodol, a muscle relaxants. It also provides Cetirizine HCl chewable tablets, which are antiallergic drugs; Choline Magnesium Trisalicylate, Flurbiprofen, Meloxicam, Salsalate, and Oxaprozin, which are used as nonsteroidal anti-inflammatory agents; Citalopram HBr, Mirtazapine, and Paroxetine, which are antidepressants; Clonazepam for the treatment of seizure and panic disorders; Clozapine, an antipsychotic; Digoxin, a cardiac drug; Glipizide, Glipizide/Metformin HCl tablets, Metformin HCl, and Metformin HCl extended release, which are antidiabetics; Hydrochlorothiazide, an antihypertensive product; and Meperidine HCl, which are narcotic and analgesic drugs.
Last Trade: 4.44
Day's Range: 4.25 - 4.44
52wk Range: 2.93 - 16.40
Volume: 36,552
Change: Up 0.14 (3.26%)
---
Tianyin Pharmaceutical Co., Inc,TPI
Tianyin Pharmaceutical Co., Inc., through its subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd., engages in the development, manufacture, marketing, and sale of traditional Chinese medicines and other pharmaceuticals in the People?s Republic of China. It manufactures a portfolio of 34 products, as well as has a pipeline of 51 products, which are pending regulatory approvals with the China State Food and Drug Administration. The company was founded in 1994 and is based in Chengdu, the People's Republic of China.
Last Trade: 2.40
Day's Range: 2.32 - 2.49
52wk Range: 0.68 - 2.55
Volume: 27,800
---
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
WhisperfromWallStreet.com (WFWS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by WFWS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. WFWS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.whisperfromwallstreet.com or mentioned herein. WFWS may have been compensated with shares or with cash from third party shareholders or the company on behalf of one or more of the companies mentioned in this opinion.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WFWS undertakes no obligation to update such statements.
This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
CONTACT: WhisperFromWallStreet.com
